The difference in os did not reach statistical significance, likely as a result of the planned crossover from placebo to everolimus on study.
← all excerpts
Targeted therapies for renal cell carcinoma: more gains from using them again.
1
—
—
The difference in os did not reach statistical significance, likely as a result of the planned crossover from placebo to everolimus on study.